Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?

被引:120
作者
Kerkis, Irina [2 ]
Ambrosio, Carlos E. [3 ]
Kerkis, Alexandre [4 ]
Martins, Daniele S. [3 ]
Zucconi, Eder [1 ]
Fonseca, Simone A. S. [2 ]
Cabral, Rosa M. [3 ]
Maranduba, Carlos M. C. [2 ]
Gaiad, Thais P. [3 ]
Morini, Adriana C. [3 ]
Vieira, Natassia M. [1 ]
Brolio, Marina P. [3 ]
Sant'Anna, Osvaldo A. [2 ]
Miglino, Maria A. [3 ]
Zatz, Mayana [1 ]
机构
[1] Univ Sao Paulo, Dept Genet & Biol Evolut, Ctr Estudos Genoma Humano, BR-05508 Sao Paulo, Brazil
[2] Inst Butantan, Lab Genet & Imunoquim, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med Vet, Dept Cirurg, BR-05508 Sao Paulo, Brazil
[4] Atividades Vet LTD, Genet Aplicada, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1186/1479-5876-6-35
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The golden retriever muscular dystrophy (GRMD) dogs represent the best available animal model for therapeutic trials aiming at the future treatment of human Duchenne muscular dystrophy (DMD). We have obtained a rare litter of six GRMD dogs (3 males and 3 females) born from an affected male and a carrier female which were submitted to a therapeutic trial with adult human stem cells to investigate their capacity to engraft into dogs muscles by local as compared to systemic injection without any immunosuppression. Methods: Human Immature Dental Pulp Stem Cells (hIDPSC) were transplanted into 4 littermate dogs aged 28 to 40 days by either arterial or muscular injections. Two non-injected dogs were kept as controls. Clinical translation effects were analyzed since immune reactions by blood exams and physical scores capacity of each dog. Samples from biopsies were checked by immunohistochemistry (dystrophin markers) and FISH for human probes. Results and Discussion: We analyzed the cells' ability in respect to migrate, engraftment, and myogenic potential, and the expression of human dystrophin in affected muscles. Additionally, the efficiency of single and consecutive early transplantation was compared. Chimeric muscle fibers were detected by immunofluorescence and fluorescent in situ hybridisation (FISH) using human antibodies and X and Y DNA probes. No signs of immune rejection were observed and these results suggested that hIDPSC cell transplantation may be done without immunosuppression. We showed that hIDPSC presented significant engraftment in GRMD dog muscles, although human dystrophin expression was modest and limited to several muscle fibers. Better clinical condition was also observed in the dog, which received monthly arterial injections and is still clinically stable at 25 months of age. Conclusion: Our data suggested that systemic multiple deliveries seemed more effective than local injections. These findings open important avenues for further researches.
引用
收藏
页数:13
相关论文
共 32 条
  • [1] Extreme clinical variability in GRMD: From neonatal death to asymptomatic carriers
    Ambrosio, C.
    Zucconi, E.
    Martins, D.
    Vanucchi, C.
    Perez, M.
    Vieira, N.
    Valadares, M.
    Jazedje, T.
    Miglino, M.
    Zatz, M.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 776 - 776
  • [2] Skeletal muscle tissue engineering
    Bach, AD
    Beier, JP
    Stern-Staeter, J
    Horch, RE
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (04): : 413 - 422
  • [3] Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism
    Camirand, G
    Rousseau, J
    Ducharme, ME
    Rothstein, DM
    Tremblay, JP
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (08) : 1255 - 1265
  • [4] Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54
  • [5] Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs
    Dell'Agnola, C
    Wang, ZJ
    Storb, R
    Tapscott, SJ
    Kuhr, CS
    Hauschka, SD
    Lee, RS
    Sale, GE
    Zellmer, E
    Gisburne, S
    Bogan, J
    Kornegay, JN
    Cooper, BJ
    Gooley, TA
    Little, MT
    [J]. BLOOD, 2004, 104 (13) : 4311 - 4318
  • [6] Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
    Di Nicola, M
    Carlo-Stella, C
    Magni, M
    Milanesi, M
    Longoni, PD
    Matteucci, P
    Grisanti, S
    Gianni, AM
    [J]. BLOOD, 2002, 99 (10) : 3838 - 3843
  • [7] DIDIO LJA, 1998, TRATADO ANATOMIA APL, P103
  • [8] Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    Dominici, M.
    Le Blanc, K.
    Mueller, I.
    Slaper-Cortenbach, I.
    Marini, F. C.
    Krause, D. S.
    Deans, R. J.
    Keating, A.
    Prockop, D. J.
    Horwitz, E. M.
    [J]. CYTOTHERAPY, 2006, 8 (04) : 315 - 317
  • [9] Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease
    Fadic, Ricardo
    Mezzano, Valeria
    Alvarez, Karin
    Cabrera, Daniel
    Holmgren, Jenny
    Brandan, Enrique
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (03) : 758 - 769
  • [10] Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction
    Gandia, Carolina
    Arminan, Ana
    Garcia-Verdugo, Jose Manuel
    Lledo, Elisa
    Ruiz, Amparo
    Minana, M. Dolores
    Sanchez-Torrijos, Jorge
    Paya, Rafael
    Mirabet, Vicente
    Carbonell-Uberos, Francisco
    Llop, Mauro
    Montero, Jose Anastasio
    Sepulveda, Pilar
    [J]. STEM CELLS, 2008, 26 (03) : 638 - 645